APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmic Suspension

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ophthalmic Suspension Market Outlook and Growth Opportunities 2026

20 December 2025198 pages

Choose your research edition.

Industry ResearchOphthalmic Suspension Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmic Suspension Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Ophthalmic Suspension Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmic Suspension Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmic Suspension Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Ophthalmic Suspension market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ophthalmic Suspension is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ophthalmic Suspension is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmic Suspension is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ophthalmic Suspension market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ophthalmic Suspension market include Novartis, Merck, Pfizer, Valeant, Falcon Group, Bausch & Lomb and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ophthalmic Suspension market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ophthalmic Suspension and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ophthalmic Suspension sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ophthalmic Suspension market size, projected growth trends, production technologies, key applications, and end-use industries.

Ophthalmic Suspension Segment by Company

Novartis

Merck

Pfizer

Valeant

Falcon Group

Bausch & Lomb

Allergan

Ophthalmic Suspension Segment by Type

NSAIDs

Antibacterial

Antibiotic

Antifungal

Steroids

Others

Ophthalmic Suspension Segment by Application

Hospital

Eye Clinic

Others

Ophthalmic Suspension Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Ophthalmic Suspension status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ophthalmic Suspension market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ophthalmic Suspension significant trends, drivers, influence factors in global and regions.

6. To analyze Ophthalmic Suspension competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Suspension market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Suspension and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Suspension.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ophthalmic Suspension market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ophthalmic Suspension industry.

Chapter 3: Detailed analysis of Ophthalmic Suspension manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ophthalmic Suspension in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ophthalmic Suspension in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ophthalmic Suspension Industry Trends Table 2. Ophthalmic Suspension Industry Drivers Table 3. Ophthalmic Suspension Industry Opportunities and Challenges Table 4. Ophthalmic Suspension Industry Restraints Table 5. Global Ophthalmic Suspension Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ophthalmic Suspension Revenue Share by Company (2021-2026) Table 7. Global Ophthalmic Suspension Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Ophthalmic Suspension Sales Volume Share by Company (2021-2026) Table 9. Global Ophthalmic Suspension Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Ophthalmic Suspension Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ophthalmic Suspension Key Company Manufacturing Base & Headquarters Table 12. Global Ophthalmic Suspension Company, Product Type & Application Table 13. Global Ophthalmic Suspension Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ophthalmic Suspension by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of NSAIDs Table 18. Significant Companies of Antibacterial Table 19. Significant Companies of Antibiotic Table 20. Significant Companies of Antifungal Table 21. Significant Companies of Steroids Table 22. Significant Companies of Others Table 23. Global Ophthalmic Suspension Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Ophthalmic Suspension Sales Volume by Type (2021-2026) & (K Units) Table 25. Global Ophthalmic Suspension Sales Volume by Type (2027-2032) & (K Units) Table 26. Global Ophthalmic Suspension Sales Volume Share by Type (2021-2026) Table 27. Global Ophthalmic Suspension Sales Volume Share by Type (2027-2032) Table 28. Global Ophthalmic Suspension Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Ophthalmic Suspension Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Ophthalmic Suspension Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Ophthalmic Suspension Sales Value Share by Type (2021-2026) Table 32. Global Ophthalmic Suspension Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Hospital Table 34. Significant Companies of Eye Clinic Table 35. Significant Companies of Others Table 36. Global Ophthalmic Suspension Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Ophthalmic Suspension Sales Volume by Application (2021-2026) & (K Units) Table 38. Global Ophthalmic Suspension Sales Volume by Application (2027-2032) & (K Units) Table 39. Global Ophthalmic Suspension Sales Volume Share by Application (2021-2026) Table 40. Global Ophthalmic Suspension Sales Volume Share by Application (2027-2032) Table 41. Global Ophthalmic Suspension Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Ophthalmic Suspension Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Ophthalmic Suspension Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Ophthalmic Suspension Sales Value Share by Application (2021-2026) Table 45. Global Ophthalmic Suspension Sales Value Share by Application (2027-2032) Table 46. Global Ophthalmic Suspension Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Ophthalmic Suspension Sales by Region (2021-2026) & (K Units) Table 48. Global Ophthalmic Suspension Sales Market Share by Region (2021-2026) Table 49. Global Ophthalmic Suspension Sales by Region (2027-2032) & (K Units) Table 50. Global Ophthalmic Suspension Sales Market Share by Region (2027-2032) Table 51. Global Ophthalmic Suspension Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Ophthalmic Suspension Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Ophthalmic Suspension Sales Value Share by Region (2021-2026) Table 54. Global Ophthalmic Suspension Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Ophthalmic Suspension Sales Value Share by Region (2027-2032) Table 56. Global Ophthalmic Suspension Market Average Price (US$/Unit) by Region (2021-2026) Table 57. Global Ophthalmic Suspension Market Average Price (US$/Unit) by Region (2027-2032) Table 58. Global Ophthalmic Suspension Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Global Ophthalmic Suspension Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Ophthalmic Suspension Sales by Country (2021-2026) & (K Units) Table 61. Global Ophthalmic Suspension Sales Market Share by Country (2021-2026) Table 62. Global Ophthalmic Suspension Sales by Country (2027-2032) & (K Units) Table 63. Global Ophthalmic Suspension Sales Market Share by Country (2027-2032) Table 64. Global Ophthalmic Suspension Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Ophthalmic Suspension Sales Value Market Share by Country (2021-2026) Table 66. Global Ophthalmic Suspension Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Ophthalmic Suspension Sales Value Market Share by Country (2027-2032) Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Ophthalmic Suspension Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Novartis Ophthalmic Suspension Product Portfolio Table 72. Novartis Recent Development Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck Ophthalmic Suspension Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Merck Ophthalmic Suspension Product Portfolio Table 77. Merck Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Ophthalmic Suspension Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Pfizer Ophthalmic Suspension Product Portfolio Table 82. Pfizer Recent Development Table 83. Valeant Company Information Table 84. Valeant Business Overview Table 85. Valeant Ophthalmic Suspension Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Valeant Ophthalmic Suspension Product Portfolio Table 87. Valeant Recent Development Table 88. Falcon Group Company Information Table 89. Falcon Group Business Overview Table 90. Falcon Group Ophthalmic Suspension Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Falcon Group Ophthalmic Suspension Product Portfolio Table 92. Falcon Group Recent Development Table 93. Bausch & Lomb Company Information Table 94. Bausch & Lomb Business Overview Table 95. Bausch & Lomb Ophthalmic Suspension Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Bausch & Lomb Ophthalmic Suspension Product Portfolio Table 97. Bausch & Lomb Recent Development Table 98. Allergan Company Information Table 99. Allergan Business Overview Table 100. Allergan Ophthalmic Suspension Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Allergan Ophthalmic Suspension Product Portfolio Table 102. Allergan Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Ophthalmic Suspension Distributors List Table 106. Ophthalmic Suspension Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Ophthalmic Suspension Product Image Figure 2. Global Ophthalmic Suspension Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmic Suspension Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ophthalmic Suspension Sales (2021-2032) & (K Units) Figure 5. Global Ophthalmic Suspension Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Ophthalmic Suspension Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. NSAIDs Image Figure 10. Antibacterial Image Figure 11. Antibiotic Image Figure 12. Antifungal Image Figure 13. Steroids Image Figure 14. Others Image Figure 15. Global Ophthalmic Suspension Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Ophthalmic Suspension Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Ophthalmic Suspension Sales Volume Share by Type (2021-2032) Figure 18. Global Ophthalmic Suspension Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Ophthalmic Suspension Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Ophthalmic Suspension Sales Value Share by Type (2021-2032) Figure 21. Hospital Image Figure 22. Eye Clinic Image Figure 23. Others Image Figure 24. Global Ophthalmic Suspension Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Ophthalmic Suspension Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Ophthalmic Suspension Sales Volume Share by Application (2021-2032) Figure 27. Global Ophthalmic Suspension Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Ophthalmic Suspension Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Ophthalmic Suspension Sales Value Share by Application (2021-2032) Figure 30. Global Ophthalmic Suspension Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 31. Global Ophthalmic Suspension Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Ophthalmic Suspension Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Ophthalmic Suspension Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Ophthalmic Suspension Sales Value (2021-2032) & (US$ Million) Figure 35. North America Ophthalmic Suspension Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Ophthalmic Suspension Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Ophthalmic Suspension Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Ophthalmic Suspension Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Ophthalmic Suspension Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Ophthalmic Suspension Sales Value (2021-2032) & (US$ Million) Figure 41. South America Ophthalmic Suspension Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Ophthalmic Suspension Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Ophthalmic Suspension Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Ophthalmic Suspension Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Ophthalmic Suspension Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Ophthalmic Suspension Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • NSAIDs
  • Antibacterial
  • Antibiotic
  • Antifungal
  • Steroids
  • Others
Applications
  • Hospital
  • Eye Clinic
  • Others
Companies covered
  • Novartis
  • Merck
  • Pfizer
  • Valeant
  • Falcon Group
  • Bausch & Lomb
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ophthalmic Suspension Sales Value (2021-2032)
  4. 1.2.2 Global Ophthalmic Suspension Sales Volume (2021-2032)
  5. 1.2.3 Global Ophthalmic Suspension Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ophthalmic Suspension Market Dynamics
  1. 2.1 Ophthalmic Suspension Industry Trends
  2. 2.2 Ophthalmic Suspension Industry Drivers
  3. 2.3 Ophthalmic Suspension Industry Opportunities and Challenges
  4. 2.4 Ophthalmic Suspension Industry Restraints
3 Ophthalmic Suspension Market by Company
  1. 3.1 Global Ophthalmic Suspension Company Revenue Ranking in 2025
  2. 3.2 Global Ophthalmic Suspension Revenue by Company (2021-2026)
  3. 3.3 Global Ophthalmic Suspension Sales Volume by Company (2021-2026)
  4. 3.4 Global Ophthalmic Suspension Average Price by Company (2021-2026)
  5. 3.5 Global Ophthalmic Suspension Company Ranking (2024-2026)
  6. 3.6 Global Ophthalmic Suspension Company Manufacturing Base and Headquarters
  7. 3.7 Global Ophthalmic Suspension Company Product Type and Application
  8. 3.8 Global Ophthalmic Suspension Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ophthalmic Suspension Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ophthalmic Suspension Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ophthalmic Suspension Market by Type
  1. 4.1 Ophthalmic Suspension Type Introduction
  2. 4.1.1 NSAIDs
  3. 4.1.2 Antibacterial
  4. 4.1.3 Antibiotic
  5. 4.1.4 Antifungal
  6. 4.1.5 Steroids
  7. 4.1.6 Others
  8. 4.2 Global Ophthalmic Suspension Sales Volume by Type
  9. 4.2.1 Global Ophthalmic Suspension Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Ophthalmic Suspension Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Ophthalmic Suspension Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Ophthalmic Suspension Sales Value by Type
  13. 4.3.1 Global Ophthalmic Suspension Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Ophthalmic Suspension Sales Value by Type (2021-2032)
  15. 4.3.3 Global Ophthalmic Suspension Sales Value Share by Type (2021-2032)
5 Ophthalmic Suspension Market by Application
  1. 5.1 Ophthalmic Suspension Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Eye Clinic
  4. 5.1.3 Others
  5. 5.2 Global Ophthalmic Suspension Sales Volume by Application
  6. 5.2.1 Global Ophthalmic Suspension Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ophthalmic Suspension Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Ophthalmic Suspension Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Ophthalmic Suspension Sales Value by Application
  10. 5.3.1 Global Ophthalmic Suspension Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ophthalmic Suspension Sales Value by Application (2021-2032)
  12. 5.3.3 Global Ophthalmic Suspension Sales Value Share by Application (2021-2032)
6 Ophthalmic Suspension Regional Sales and Value Analysis
  1. 6.1 Global Ophthalmic Suspension Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ophthalmic Suspension Sales by Region (2021-2032)
  3. 6.2.1 Global Ophthalmic Suspension Sales by Region: 2021-2026
  4. 6.2.2 Global Ophthalmic Suspension Sales by Region (2027-2032)
  5. 6.3 Global Ophthalmic Suspension Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ophthalmic Suspension Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ophthalmic Suspension Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ophthalmic Suspension Sales Value by Region (2027-2032)
  9. 6.5 Global Ophthalmic Suspension Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ophthalmic Suspension Sales Value (2021-2032)
  12. 6.6.2 North America Ophthalmic Suspension Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ophthalmic Suspension Sales Value (2021-2032)
  15. 6.7.2 Europe Ophthalmic Suspension Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ophthalmic Suspension Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ophthalmic Suspension Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ophthalmic Suspension Sales Value (2021-2032)
  21. 6.9.2 South America Ophthalmic Suspension Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ophthalmic Suspension Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ophthalmic Suspension Sales Value Share by Country, 2025 VS 2032
7 Ophthalmic Suspension Country-level Sales and Value Analysis
  1. 7.1 Global Ophthalmic Suspension Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ophthalmic Suspension Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ophthalmic Suspension Sales by Country (2021-2032)
  4. 7.3.1 Global Ophthalmic Suspension Sales by Country (2021-2026)
  5. 7.3.2 Global Ophthalmic Suspension Sales by Country (2027-2032)
  6. 7.4 Global Ophthalmic Suspension Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ophthalmic Suspension Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ophthalmic Suspension Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ophthalmic Suspension Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ophthalmic Suspension Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ophthalmic Suspension Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Ophthalmic Suspension Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Ophthalmic Suspension Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Ophthalmic Suspension Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Ophthalmic Suspension Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Ophthalmic Suspension Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Ophthalmic Suspension Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Valeant
  20. 8.4.1 Valeant Company Information
  21. 8.4.2 Valeant Business Overview
  22. 8.4.3 Valeant Ophthalmic Suspension Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Valeant Ophthalmic Suspension Product Portfolio
  24. 8.4.5 Valeant Recent Developments
  25. 8.5 Falcon Group
  26. 8.5.1 Falcon Group Company Information
  27. 8.5.2 Falcon Group Business Overview
  28. 8.5.3 Falcon Group Ophthalmic Suspension Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Falcon Group Ophthalmic Suspension Product Portfolio
  30. 8.5.5 Falcon Group Recent Developments
  31. 8.6 Bausch & Lomb
  32. 8.6.1 Bausch & Lomb Company Information
  33. 8.6.2 Bausch & Lomb Business Overview
  34. 8.6.3 Bausch & Lomb Ophthalmic Suspension Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bausch & Lomb Ophthalmic Suspension Product Portfolio
  36. 8.6.5 Bausch & Lomb Recent Developments
  37. 8.7 Allergan
  38. 8.7.1 Allergan Company Information
  39. 8.7.2 Allergan Business Overview
  40. 8.7.3 Allergan Ophthalmic Suspension Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Allergan Ophthalmic Suspension Product Portfolio
  42. 8.7.5 Allergan Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ophthalmic Suspension Value Chain Analysis
  2. 9.1.1 Ophthalmic Suspension Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ophthalmic Suspension Sales Mode & Process
  6. 9.2 Ophthalmic Suspension Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ophthalmic Suspension Distributors
  9. 9.2.3 Ophthalmic Suspension Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst